BKS Advisors’s Bristol-Myers Squibb BMY Stock Holding History

BKS Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$285K	Hold	5,978	–	–	0.11%	170
2018 Q4	$311K	Sell	5,978 -2,227	-27%	-$120K	0.14%	147
2018 Q3	$509K	Sell	8,205 -5,350	-39%	-$317K	0.19%	128
2018 Q2	$750K	Buy	13,555 +570	+4%	+$30.8K	0.27%	90
2018 Q1	$821K	Hold	12,985	–	–	0.3%	83
2017 Q4	$796K	Buy	12,985 +200	+2%	+$12.5K	0.29%	83
2017 Q3	$815K	Sell	12,785 -600	-4%	-$35K	0.32%	78
2017 Q2	$746K	Buy	13,385 +300	+2%	+$16.3K	0.3%	85
2017 Q1	$712K	Buy	13,085 +400	+3%	+$21.9K	0.31%	84
2016 Q4	$741K	Sell	12,685 -5	-0%	-$273	0.35%	80
2016 Q3	$684K	Buy	12,690 +2,410	+23%	+$155K	0.32%	79
2016 Q2	$756K	Sell	10,280 -2,100	-17%	-$148K	0.39%	71
2016 Q1	$791K	Sell	12,380 -1,600	-11%	-$101K	0.41%	68
2015 Q4	$962K	Buy	13,980 +1,000	+8%	+$66.1K	0.49%	62
2015 Q3	$768K	Buy	12,980 +289	+2%	+$18.3K	0.43%	60
2015 Q2	$844K	Buy	12,691 +1,850	+17%	+$122K	0.4%	60
2015 Q1	$699K	Buy	+10,841	New	+$679K	0.33%	65

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BKS Advisors's BMY Position: Q1 2019 in Review

BKS Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2019 at 5,978 shares worth $285K. The position accounts for 0.11% of the portfolio, ranked #170.

BKS Advisors first reported a position in BMY in Q1 2015 and has held it in 17 quarters since. The position peaked at $962K in Q4 2015. 1,813 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

BKS Advisors held 5,978 shares of Bristol-Myers Squibb worth $285K as of Q1 2019.
BKS Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2019.
Bristol-Myers Squibb made up 0.11% of BKS Advisors's portfolio in Q1 2019, its #170 holding.
BKS Advisors first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 17 quarters since.
BKS Advisors's Bristol-Myers Squibb position peaked at $962K in Q4 2015.
1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on BKS Advisors's 13F filing for Q1 2019, filed 16 Apr 2019.